male contraceptive pill could be tested in humans in just two months, scientists say — after it showed promise in trials on mice.
Researchers at the University of Minnesota, who invented the drug, say it could enter clinical trials as early as this July.
The non-hormonal pill, medically named YCT529, blocked 99 per cent of pregnancies in mice during tests — putting it on a par with the female birth control medication.
It also did not trigger any visible side-effects, such as weight gain, and male mice were able to father pups four to six weeks after administration was stopped.
Dr Gunda Georg, a chemist at the Minneapolis-based school, revealed to Vice that the drug could enter human trials in ‘the second half of this year’.
She said the previous trials showed it had the ‘desired effect’ in mice, while also ensuring they remain ‘viable and healthy’.
